Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 564 | 205 | 274 | 36 | 1,742 |
| Cost of Goods | 242 | 296 | 194 | N/A | N/A |
| Gross Profit | 322 | -91 | 79 | 36 | 1,742 |
| Operating Expenses | 13,007 | 11,559 | 7,335 | 1,322 | 1,431 |
| Operating Income | -12,443 | -11,354 | -7,062 | -1,287 | 311 |
| Interest Expense | 0 | 0 | 0 | 10 | 486 |
| Other Income | 87 | -5 | 30 | 530 | 0 |
| Pre-tax Income | -12,356 | -11,359 | -7,032 | -766 | -175 |
| Net Income Continuous | -12,356 | -11,359 | -7,032 | -766 | -175 |
| Net Income Discontinuous | -3,119 | -2,439 | N/A | N/A | N/A |
| Net Income | $-15,475 | $-13,797 | $-7,032 | $-766 | $-175 |
| EPS Basic Total Ops | -1.79 | -2.38 | -2.24 | -0.50 | 0.00 |
| EPS Basic Continuous Ops | -1.43 | -1.96 | -2.24 | -0.50 | 0.00 |
| EPS Basic Discontinuous Ops | -0.36 | -0.42 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.79 | -2.38 | -2.24 | -0.50 | 0.00 |
| EPS Diluted Continuous Ops | -1.43 | -1.96 | -2.24 | -0.50 | 0.00 |
| EPS Diluted Discontinuous Ops | -0.36 | -0.42 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.43 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,952 | $-6,253 | $-6,960 | $-1,287 | $311 |